13D Filing: Celgene Corp /de/ and Alliqua Biomedical Inc. (NASDAQ:ALQA)

Page 5 of 7 – SEC Filing

SIGNATURE

 

After reasonable inquiry and to the best
of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

March 28, 2017

CELGENE CORPORATION
By: /s/ Peter N. Kellogg
Peter N. Kellogg
Executive Vice President and Chief Financial Officer

Follow Adynxx Inc. (NASDAQ:ADYX)